Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Journal of Crohn'S & Colitis
|
March 31, 2022
Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients
Karin Cerna, Dana Duricova, Miroslav Hindos, et al.
Gastrointestinal Endoscopy
|
June 15, 2020
Novel porcine model of Crohn's disease anastomotic stricture suitable for evaluation and training of advanced endoscopic techniques
Martin Lukas, Martin Kolar, Ondrej Ryska, et al.
Surgical Endoscopy
|
March 4, 2021
A novel postgraduate endoscopic course using a large animal model of secondary Crohn's disease stricture
Martin Lukas, Martin Kolar, Ondrej Ryska, et al.
Crohn'S & Colitis 360
|
November 29, 2023
Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?
Karin Cerna, Dana Duricova, Martin Lukas, et al.
Gastrointestinal Endoscopy
|
October 27, 2018
Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group
Bo Shen, Gursimran Kochhar, Udayakumar Navaneethan, et al.
Inflammatory Bowel Diseases
|
September 22, 2018
Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation
Dana Duricova, Eva Dvorakova, Ondrej Hradsky, et al.
Journal of Crohn'S & Colitis
|
April 24, 2016
Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis
Klaudia Farkas, Mariann Rutka, Petra A Golovics, et al.
Expert Opinion on Biological Therapy
|
October 3, 2018
Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort
Anita Bálint, Mariann Rutka, Martin Kolar, et al.
Expert Opinion on Drug Safety
|
May 16, 2017
Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort
Anita Bálint, Mariann Rutka, Zsuzsanna Végh, et al.
The Lancet. Gastroenterology & Hepatology
|
January 20, 2020
Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group
Bo Shen, Gursimran Kochhar, Udayakumar Navaneethan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Journal of Crohn'S & Colitis
|
March 31, 2022
Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients
Karin Cerna, Dana Duricova, Miroslav Hindos, et al.
Gastrointestinal Endoscopy
|
June 15, 2020
Novel porcine model of Crohn's disease anastomotic stricture suitable for evaluation and training of advanced endoscopic techniques
Martin Lukas, Martin Kolar, Ondrej Ryska, et al.
Surgical Endoscopy
|
March 4, 2021
A novel postgraduate endoscopic course using a large animal model of secondary Crohn's disease stricture
Martin Lukas, Martin Kolar, Ondrej Ryska, et al.
Crohn'S & Colitis 360
|
November 29, 2023
Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?
Karin Cerna, Dana Duricova, Martin Lukas, et al.
Gastrointestinal Endoscopy
|
October 27, 2018
Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group
Bo Shen, Gursimran Kochhar, Udayakumar Navaneethan, et al.
Inflammatory Bowel Diseases
|
September 22, 2018
Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation
Dana Duricova, Eva Dvorakova, Ondrej Hradsky, et al.
Journal of Crohn'S & Colitis
|
April 24, 2016
Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis
Klaudia Farkas, Mariann Rutka, Petra A Golovics, et al.
Expert Opinion on Biological Therapy
|
October 3, 2018
Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort
Anita Bálint, Mariann Rutka, Martin Kolar, et al.
Expert Opinion on Drug Safety
|
May 16, 2017
Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort
Anita Bálint, Mariann Rutka, Zsuzsanna Végh, et al.
The Lancet. Gastroenterology & Hepatology
|
January 20, 2020
Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group
Bo Shen, Gursimran Kochhar, Udayakumar Navaneethan, et al.
Page
of 3